References
- KimYSKimTHChoiCSEffect of itopride, a new prokinetic, in patients with mild GERD: a pilot studyWorld J Gastroenterol200511274210421416015691
- IwanagaYMiyashitaNSaitoTMorikawaKItohZGastroprokinetic effect of a new benzamide derivative itopride and its action mechanisms in conscious dogsJpn J Pharmacol19967121291378835639
- BoseAWongTWSinghNFormulation development and optimization of sustained release matrix tablet of itopride HCl by response surface methodology and its evaluation of release kineticsSaudi Pharm J201321220121323960836
- HoltmannGTalleyNJLiebregtsTAdamBParowCA placebo-controlled trial of itopride in functional dyspepsiaN Engl J Med2006354883284016495395
- SatapathyTPandaPKGoyalAKRathGEvaluation of anti-GERD activity of gastro retentive drug delivery system of itopride hydrochlorideArtif Cells Blood Substit Immobil Biotechnol201038420020720515421
- MoësAJGastroretentive dosage formsCrit Rev Ther Drug Carrier Syst1992102143195
- ShethPRTossounianJThe hydrodynamically balanced system (HBS™): a novel drug delivery system for oral useDrug Dev Ind Pharm1984102313339
- VoAQFengXMorottJTA novel floating controlled release drug delivery system prepared by hot-melt extrusionEur J Pharm Biopharm20169810812126643801
- KesarlaRSVoraPASridharBKPatelGOmriAFormulation and evaluation of floating tablet of H2-receptor antagonistDrug Dev Ind Pharm20154191499151125243639
- BaumgartnerSKristlJVrecerFVodopivecPZorkoBOptimisation of floating matrix tablets and evaluation of their gastric residence timeInt J Pharm2000195112513510675690
- ReddyLHMurthyRSFloating dosage systems in drug deliveryCrit Rev Ther Drug Carrier Syst200219655358512822735
- LiSLinSDaggyBPMirchandaniHLChienYWEffect of HPMC and carbopol on the release and floating properties of gastric floating drug delivery system using factorial designInt J Pharm20032531132212593933
- SauzetCClaeys-BrunoMNicolasMKisterJPiccerellePPrinderrePAn innovative floating gastro retentive dosage system: formulation and in vitro evaluationInt J Pharm20093781232919465095
- StreubelASiepmannJBodmeierRFloating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug releaseEur J Pharm Sci2003181374512554071
- LachmanLLiebermanHAKanigJLThe Theory and Practice of Industrial PharmacyPhiladelphia, NYLea & Febiger19861
- TadrosMIControlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteersEur J Pharm Biopharm201074233233919932750
- SrivastavaAKWadhwaSRidhurkarDMishraBOral sustained delivery of atenolol from floating matrix tablets-formulation and in vitro evaluationDrug Dev Ind Pharm2005314–536737416093202
- StrübingSMetzHMäderKCharacterization of poly (vinyl acetate) based floating matrix tabletsJ Control Release2008126214915518180069
- WagnerJGLinear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the dataJ Pharmacokinet Biopharm1976454434671003329
- USP-23, NUnited State Pharmacopoeia – XXIII National Formulary-XXIIIRockville, MDUnited State Pharmacopoeia Convention, INC.199516251626
- MachidaYInouyeKTokumuraTIwataMNagaiTPreparation and evaluation of intragastric buoyant preparationsDrug Des Deliv1989421551612765108
- ChoiBYParkHJHwangSJParkJBPreparation of alginate beads for floating drug delivery system: effects of CO(2) gas-forming agentsInt J Pharm20022391819112052693
- GerogiannisVSRekkasDMDallasPPChoulisNHFloating and swelling characteristics of various excipients used in controlled release technologyDrug Dev Ind Pharm199319910611081
- ChungMChiaWWanWLinYSungHControlled release of an anti-inflammatory drug using an ultrasensitive ROS-responsive gas-generating carrier for localized inflammation inhibitionJ Am Chem Soc2016137391246212465
- Sanchez-LafuenteCFaucciMTFernández-ArévaloMÁlvarez-FuentesJRabascoAMMuraPDevelopment of sustained release matrix tablets of didanosine containing methacrylic and ethylcellulose polymersInt J Pharm2002234121322111839452
- HorhotaSTBurgioJLonskiLRhodesCTEffect of storage at specified temperature and humidity on properties of three directly compressible tablet formulationsJ Pharm Sci19766512174617491032656
- GoskondaVRReddyIKDurraniMJWilberWKhanMASolid-state stability assessment of controlled release tablets containing carbopol 971PJ Control Release199854187939741906
- HosnyEAStudy of accelerated storage conditions affecting physical characteristics, in-vitro dissolution and stability of bioadhesive containing tabletsBoll Chim Farm1999138624324810464972